NG2 proteoglycan promotes angiogenesis‐dependent tumor growth in the central nervous system by sequestering angiostatin

During embryogenesis, the NG2 proteoglycan is expressed on immature capillary vessels, but as the vessels mature they lose this expression. NG2 is up‐regulated in high‐grade gliomas, but it is not clear to what extent it contributes to malignant progression. Using a combination of high spatial and temporal resolution functional magnetic resonance imaging and histopathological analyses, we show here that overexpression of NG2 increases tumor initiation and growth rates, neovascularization, and cellular proliferation, which predisposes to a poorer survival outcome. By confocal microscopy and cDNA gene array expression profiles, we also show that NG2 tumors express lower levels of hypoxia inducible factor‐1α, vascular endothelial growth factor, and endogenous angiostatin in vivo compared with wild‐type tumors. Moreover, we demonstrate that NG2‐positive cells bind, internalize, and coimmunoprecipitate with angiostatin. These results indicate a unique role for NG2 in regulating the transition from small, poorly vascularized tumors to large, highly vascular gliomas in situ by sequestering angiostatin.

[1]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[2]  G. Breier,et al.  Hypoxia-induced Transcriptional Activation and Increased mRNA Stability of Vascular Endothelial Growth Factor in C6 Glioma Cells (*) , 1995, The Journal of Biological Chemistry.

[3]  R Pasqualini,et al.  NG2 proteoglycan-binding peptides target tumor neovasculature. , 1999, Cancer research.

[4]  R. Bjerkvig,et al.  Extracellular matrix-induced cell migration from glioblastoma biopsy specimens in vitro , 1999, Acta Neuropathologica.

[5]  C. Heldin,et al.  Co‐localization of NG2 proteoglycan and PDGF α‐receptor on O2A progenitor cells in the developing rat brain , 1996, Journal of neuroscience research.

[6]  O Nalcioglu,et al.  Measurement of vascular volume fraction and blood‐tissue permeability constants with a pharmacokinetic model: Studies in rat muscle tumors with dynamic Gd‐DTPA enhanced MRI , 1994, Magnetic resonance in medicine.

[7]  W. Haenszel,et al.  Statistical aspects of the analysis of data from retrospective studies of disease. , 1959, Journal of the National Cancer Institute.

[8]  W. Stallcup,et al.  Participation of the NG2 proteoglycan in rat aortic smooth muscle cell responses to platelet-derived growth factor. , 1995, Experimental cell research.

[9]  M. Raff Glial cell diversification in the rat optic nerve. , 1989, Science.

[10]  P. D’Amore,et al.  Capillary growth: a two-cell system. , 1992, Seminars in Cancer Biology.

[11]  W. Stallcup,et al.  High-affinity Binding of Basic Fibroblast Growth Factor and Platelet-derived Growth Factor-AA to the Core Protein of the NG2 Proteoglycan* , 1999, The Journal of Biological Chemistry.

[12]  A. Olivier,et al.  NG2 immunoreactivity on human brain endothelial cells , 2001, Acta Neuropathologica.

[13]  A. Nishiyama,et al.  Expression of NG2 proteoglycan causes retention of type VI collagen on the cell surface. , 1993, Molecular biology of the cell.

[14]  F. Gage,et al.  Proliferation and Differentiation of Progenitor Cells Throughout the Intact Adult Rat Spinal Cord , 2000, The Journal of Neuroscience.

[15]  D. Ruiter,et al.  Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue. , 1991, The American journal of pathology.

[16]  G. Semenza Transcriptional regulation by hypoxia-inducible factor 1 molecular mechanisms of oxygen homeostasis. , 1996, Trends in cardiovascular medicine.

[17]  C. Lombardo,et al.  Binding of the NG2 Proteoglycan to Kringle Domains Modulates the Functional Properties of Angiostatin and Plasmin(ogen)* , 2000, The Journal of Biological Chemistry.

[18]  A. Nishiyama,et al.  A central segment of the NG2 proteoglycan is critical for the ability of glioma cells to bind and migrate toward type VI collagen. , 1997, Experimental cell research.

[19]  I. Bernstein,et al.  Human homologue of the rat chondroitin sulfate proteoglycan, NG2, detected by monoclonal antibody 7.1, identifies childhood acute lymphoblastic leukemias with t(4;11)(q21;q23) or t(11;19)(q23;p13) and MLL gene rearrangements. , 1996, Blood.

[20]  M. Melamed,et al.  Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues. , 1985, Cancer research.

[21]  E. Keshet,et al.  A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. , 1998, Development.

[22]  J. Levine Increased expression of the NG2 chondroitin-sulfate proteoglycan after brain injury , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[23]  W. Stallcup,et al.  Expression of the NG2 proteoglycan enhances the growth and metastatic properties of melanoma cells , 1998, Journal of cellular physiology.

[24]  J. Yuhas,et al.  A simplified method for production and growth of multicellular tumor spheroids. , 1977, Cancer research.

[25]  J. Prince,et al.  The primary structure of NG2, a novel membrane-spanning proteoglycan , 1991, The Journal of cell biology.

[26]  G. Yancopoulos,et al.  Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF. , 1999, Science.

[27]  S. Weiss,et al.  Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. , 1992, Science.

[28]  W. Stallcup,et al.  NG2 proteoglycan expression by pericytes in pathological microvasculature. , 2002, Microvascular research.

[29]  P. Tofts,et al.  Measurement of the blood‐brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts , 1991, Magnetic resonance in medicine.

[30]  M. Schrappe,et al.  Correlation of chondroitin sulfate proteoglycan expression on proliferating brain capillary endothelial cells with the malignant phenotype of astroglial cells. , 1991, Cancer research.

[31]  R. Reisfeld,et al.  Inhibition of anchorage-independent growth of human melanoma cells by a monoclonal antibody to a chondroitin sulfate proteoglycan. , 1983, Journal of the National Cancer Institute.

[32]  W. Stallcup,et al.  NG2 proteoglycan is expressed exclusively by mural cells during vascular morphogenesis , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[33]  R. Gillies,et al.  Applications of magnetic resonance in model systems: tumor biology and physiology. , 2000, Neoplasia.

[34]  D. Barritt,et al.  Cytoskeletal reorganization induced by engagement of the NG2 proteoglycan leads to cell spreading and migration. , 1999, Molecular biology of the cell.

[35]  P A D'Amore,et al.  Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.

[36]  W. Stallcup,et al.  Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan , 1987, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[37]  E. Kaplan,et al.  Nonparametric Estimation from Incomplete Observations , 1958 .

[38]  N. Kaplan,et al.  Monoclonal antibody and an antibody-toxin conjugate to a cell surface proteoglycan of melanoma cells suppress in vivo tumor growth. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[39]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[40]  S Ferrone,et al.  Expression of the high molecular weight melanoma-associated antigen by pericytes during angiogenesis in tumors and in healing wounds. , 1989, The American journal of pathology.

[41]  Jonas Frisén,et al.  Identification of a Neural Stem Cell in the Adult Mammalian Central Nervous System , 1999, Cell.

[42]  Y. Shoshan,et al.  Expression of oligodendrocyte progenitor cell antigens by gliomas: implications for the histogenesis of brain tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Folkman Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.